Treatment of fibrotic interstitial lung disease: current approaches and future directions

Kerri A Johannson, Nazia Chaudhuri, Ayodeji Adegunsoye, Paul J Wolters

Research output: Contribution to journalReview articlepeer-review

42 Citations (Scopus)


Fibrotic interstitial lung disease (ILD) represents a large group of pulmonary disorders that are often progressive and associated with high morbidity and early mortality. Important advancements in the past 10 years have enabled a better understanding, characterisation, and treatment of these diseases. This Series paper summarises the current approach to treatment of fibrotic ILDs, both pharmacological and non-pharmacological, including recent discoveries and practice-changing clinical trials. We further outline controversies and challenges, with discussion of evolving concepts and future research directions.

Original languageEnglish
Pages (from-to)1450-1460
Number of pages11
Issue number10309
Early online date6 Sept 2021
Publication statusPublished (in print/issue) - 16 Oct 2021

Bibliographical note

Copyright © 2021 Elsevier Ltd. All rights reserved.


  • Humans
  • Lung Diseases, Interstitial/drug therapy
  • Pulmonary Fibrosis/drug therapy


Dive into the research topics of 'Treatment of fibrotic interstitial lung disease: current approaches and future directions'. Together they form a unique fingerprint.

Cite this